Zobrazeno 1 - 10
of 703
pro vyhledávání: '"R Camargo"'
Autor:
ARF Fingolo, EB Riscarolli, CA Abraham, PM Lima, GSGA Xavier, E Oliveira, PFR Siqueira, RC Torres, VC Lisboa, R Camargo, RM Pontes, CSF Facio, ES Costa
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S196- (2024)
Células tumorais metastáticas na medula óssea são encontradas em cerca de 15% dos pacientes pediátricos ao diagnóstico. A detecção precisa do envolvimento metastático é essencial para o estadiamento, estratificação terapêutica e prognós
Externí odkaz:
https://doaj.org/article/3a7f945ac09640fda7780044911b4b6c
Autor:
MCC Magalhães, RM Pontes, FM Furtado, BC Guido, ACMD Santos-Junior, RA Toscano, IMQ Magalhães, R Camargo, JCM Códoba
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S198-S199 (2024)
Introduction: Measurable residual disease (MRD) has been reported as a strong independent prognostic factor in AML, particularly in guiding decisions for hematopoietic cell transplantation in first remission. The recent consensus guidelines establish
Externí odkaz:
https://doaj.org/article/b9b668f796cd497f9f97606a2d66c1e2
Autor:
CA Abraham, EB Riscarolli, ARF Fíngolo, PM Lima, GSGA Xavier, VC Lisboa, E Oliveira, PFR Siqueira, RC Torres, R Camargo, RM Pontes, CSF Facio, ES Costa
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S196-S197 (2024)
Objetivos: Células tumorais circulantes (CTCs) são células raras no sangue periférico de pacientes com câncer, refletindo o estado tumoral em tempo real. A detecção de CTCs pode indicar disseminação metastática e formação de micrometásta
Externí odkaz:
https://doaj.org/article/2309135ed30946449fd1f658df775c42
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S344-S345 (2024)
Introdução: Apesar das elevadas taxas de sobrevida das Leucemias Linfoides Agudas de células B (LLA-B) na infância, o manejo de pacientes com recidiva ou refratariedade à terapia ainda é um desafio. A elucidação da leucemogênese por meio do
Externí odkaz:
https://doaj.org/article/96b580b6d39742d889f652dcd4d7a2e7
Autor:
CS Sanches, R Camargo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S378- (2024)
Objetivos: Verificar e comparar os impactos das deleções nos genes CDKN2A e 2B (delCDKN2A/B) em uma amostra de crianças latinas diagnosticadas com LLA-B em um hospital pediátrico de referência do Distrito Federal. Métodos: Incluiu-se 21 pacient
Externí odkaz:
https://doaj.org/article/dadbebeeb36c489ba1f819f26c9d1b77
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S422-S423 (2024)
Introduction: Oncohematological neoplasms are the most common disorders in children. However, few studies address the epidemiology of pediatric cancer, a fundamental aspect for decision-making in the management of this complex condition. Aim: This st
Externí odkaz:
https://doaj.org/article/0b90924460d743b7aad62b1da11ef056
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S661- (2024)
Objectives: To analyze the overall survival (OS) and disease-free survival (DFS) in pediatric patients diagnosed with Ph-negative B-cell Acute Lymphoblastic leukemia (B-ALL) who underwent treatment with Blinatumomab for relapse/refractory disease. Ma
Externí odkaz:
https://doaj.org/article/7719c40e163a4f79b66fc14de2556f5f
Autor:
JLC Souza, RM Pontes, FM Furtado, MC Ribeiro, BC Guido, ACS Dias, ACMD Santo-Junior, RA Toscano, R Camargo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S301-S302 (2023)
Introdução: Neoplasias de células mastocíticas (CM) compõem um grupo heterogêneo de doenças, mas com apresentação clínica semelhante, sendo a histopatologia e biologia molecular (BM) essenciais para diagnóstico diferencial. Na Leucemia Mie
Externí odkaz:
https://doaj.org/article/7d5e53dc9489494eb8d366a5b39cada3
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S574-S575 (2023)
Objectives: Determine minimal residual disease in children with acute lymphoblastic leukemia in treatment at the Children's Hospital of Brasilia according to the BFM 2009 adapted protocol; Evaluate risk stratification and molecular alterations as pro
Externí odkaz:
https://doaj.org/article/a08b64c0110e4a1da491015d08291288
Autor:
RM Pontes, FM Furtado, SCR Franco, RA Toscano, TF Nunes, ACS Dias, JCM Cordoba, ACMDS Junior, R Camargo, IMM Quezado
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S587-S588 (2023)
Introduction: The recent active use of immunotherapy based on CD19/CD3 bispecific T-cell engager (blinatumomab), brings significant problems on monitoring Minimal Residual Disease (MRD) based on Multiparameter Flow Cytometry (MFC), due to possible CD
Externí odkaz:
https://doaj.org/article/6f0770670d174462a7c9229879d27ddd